|
1
|
Gonzalez-Angulo AM, Morales-Vasquez F and
Hortobagyi GN: Overview of resistance to systemic therapy in
patients with breast cancer. Adv Exp Med Biol. 608:1–22. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Laurentiis A, Pardo OE, Palamidessi A,
Jackson SP, Schoenwaelder SM, Reichmann E, Scita G and Arcaro A:
The catalytic class I(A) PI3K isoforms play divergent roles in
breast cancer cell migration. Cell Signal. 23:529–541. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bailly C: topoisomerase I poisons and
suppressors as anticancer drugs. Curr Med Chem. 7:39–58. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Housman G, Byler S, Heerboth S, Lapinska
K, Longacre M, Snyder N and Sarkar S: drug resistance in cancer: An
overview. Cancers (Basel). 6:1769–1792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Samet JM, Avila-Tang E, Boffetta P, Hannan
LM, Olivo-Marston S, Thun MJ and Rudin CH: Lung cancer in never
smokers: Clinical epidemiology and environmental risk factors. Clin
Cancer Res. 15:5626–5645. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cancer among adults from exposure to
secondhand smoke, The health consequences of involuntary exposure
to tobacco smoke: A Report of the Surgeon General. Atlanta (GA):
Centers for Disease Control and Prevention (US); 2006
|
|
8
|
Benowitz NL: Biomarkers of Cigarette
SmokingMonograph 7: The FTC Cigarette Test Method for Detemining
Tar, Nicotine, and Carbon Monoxide Yields of U.S. Cigarettes.
National Cancer Institute; Bethesda, MD: pp. 93–111. 1988
|
|
9
|
Centers for Disease Control and Prevention
(US); National Center for Chronic Disease Prevention and Health
Promotion (US); Office on Smoking and Health (US): Nicotine
Addiction: Past and PresentHow Tobacco Smoke Causes Disease: The
Biology and Behavioral Basis for Smoking-Attributable Disease: A
Report of the Surgeon General. Centers for Disease Control and
Prevention (US); Atlanta, GA: 2010
|
|
10
|
Dani JA and De Biasi M: Cellular
mechanisms of nicotine addiction. Pharmacol Biochem Behav.
70:439–446. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Clark CA, McEachern MD, Shah SH, Rong Y,
Rong X, Smelley CL, Caldito GC, Abreo FW and Nathan CO: Curcumin
inhibits carcinogen and nicotine-induced mammalian target of
rapamycin pathway activation in head and neck squamous cell
carcinoma. Cancer Prev Res (Phila). 3:1586–1595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schaal C and Chellappan SP:
Nicotine-mediated cell proliferation and tumor progression in
smoking-related cancers. Mol Cancer Res. 12:14–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Heeschen C, Jang JJ, Weis M, Pathak A,
Kaji S, Hu RS, Tsao PS, Johnson FL and Cooke JP: Nicotine
stimulates angiogenesis and promotes tumor growth and
atherosclerosis. Nat Med. 7:833–839. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Petros WP, Younis IR, Ford JN and Weed SA:
Effects of tobacco smoking and nicotine on cancer treatment.
Pharmacotherapy. 32:920–931. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh S, Pillai S and Chellappan S:
Nicotinic acetylcholine receptor signaling in tumor growth and
metastasis. J Oncol. 2011:4567432011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suraneni MV and Badeaux MD:
Tumor-Initiating cells, cancer metastasis and therapeutic
implications, madame curie bioscience databaseMadame Curie
Bioscience Database [Internet]. Landes Bioscience; Austin, TX:
2013
|
|
17
|
Davis R, Rizwani W, Banerjee S, Kovacs M,
Haura E, Coppola D and Chellappan S: Nicotine promotes tumor growth
and metastasis in mouse models of lung cancer. PLoS One.
4:e75242009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Honeth G, Bendahl PO, Ringner M, Saal LH,
Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A and
Hegardt C: The CD44+/CD24− phenotype is
enriched in basal-like breast tumors. Breast Cancer Res.
10:R532008. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lorico A and Rappa G: Phenotypic
heterogeneity of breast cancer stem cells. J Oncol.
2011:1350392011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong
C, Huang Y, Hu X, Su F, Lieberman J and Song E: let-7 Regulates
self renewal and tumorigenicity of breast cancer cells. Cell.
131:1109–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De Laurentiis M, Cianniello D, Caputo R,
Stanzione B, Arpino G, Cinieri S, Lorusso V and De Placido S:
Treatment of triple negative breast cancer (TNBC): Current options
and future perspectives. Cancer Treat Rev. 36 Suppl 3:S80–S86.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Muñoz-Pinedo C, El Mjiyad N and Ricci JE:
Cancer metabolism: Current perspectives and future directions. Cell
Death Dis. 3:e2482012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rivera E and Gomez H: Chemotherapy
resistance in metastatic breast cancer: The evolving role of
ixabepilone. Breast Cancer Res. 12 Suppl 2:S22010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park SY, Lee HE, Li H, Shipitsin M, Gelman
R and Polyak K: Heterogeneity for stemcell-related markers
according to tumor subtype and histologic stage in breast cancer.
Clin Cancer Res. 16:876–887. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hussain T and Nguyen QT: Molecular imaging
for cancer diagnosis and surgery. Adv Drug Deliv Rev. 66:90–100.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Groebel K, Hoelzle K, Wittenbrink MM,
Ziegler U and Hoelzle LE: Mycoplasma suis invades porcine
erythrocytes. Infect Immun. 77:576–584. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Varol B, Bektaş M, Nurten R and Bermek E:
The cytotoxic effect of diphtheria toxin on the actin cytoskeleton.
Cell Mol Biol Lett. 17:49–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mitchell RR, Szabo E, Benoit YD, Case DT,
Mechael R, Alamilla J, Lee HJ, Fiebig-Comyn A, Gillespie DC and
Bhatia M: Activation of neural cell fate programs toward direct
conversion of adult human fibroblasts into tri-potent neural
progenitors using OCT-4. Stem Cells Dev. 23:1937–1946. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jensen K, Afroze S, Munshi MK, Guerrier M
and Glaser SS: Mechanisms for nicotine in the development and
progression of gastrointestinal cancers. Transl Gastrointest
Cancer. 1:81–87. 2012.PubMed/NCBI
|
|
31
|
Karamboulas C and Ailles L: Developmental
signaling pathways in cancer stem cells of solid tumors. Biochim
Biophys Acta. 1830:2481–2495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pereira ML, Carvalho JC, Peres F,
Gutierres M and Fernandes MH: Behaviour of human osteoblastic cells
cultured on plasma-sprayed titanium implants in the presence of
nicotine. Clin Oral Implants Res. 19:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Berger MR and Zeller WJ: Interaction of
nicotine with anticancer treatment. Klin Wochenschr. 66 Suppl
11:S127–S133. 1988.
|
|
34
|
Benowitz NL, Hukkanen J and Jacob P III:
Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp
Pharmacol. 29–60. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hukkanen J, Jacob P III and Benowitz NL:
Metabolism and disposition kinetics of nicotine. Pharmacol Rev.
57:79–115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Russell MA, Feyerabend C and Cole PV:
Plasma nicotine levels after cigarette smoking and chewing nicotine
gum. Br Med J. 1:1043–1046. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sobus SL and Warren GW: The biologic
effects of cigarette smoke on cancer cells. Cancer. 120:3617–2627.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Warren GW and Singh AK: Nicotine and lung
cancer. J Carcinog. 12:12013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wei W and Lewis MT: Identifying and
targeting tumor-initiating cells in the treatment of breast cancer.
Endocr Relat Cancer. 22:R135–R155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Murin S and Inciardi J: Cigarette smoking
and the risk of pulmonary metastasis from breast cancer. Chest.
119:1635–1640. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pomorski P, Wasik A, Kołodziejczyk J,
GrêBecka L and Kłopocka W: Nicotine affects behaviour, morphology
and cortical cytoskeleton of amoeba proteus. Acta Protozool.
43:193–198. 2004.
|
|
42
|
Krause RM, Buisson B, Bertrand S,
Corringer PJ, Galzi JL, Changeux JP and Bertrand D: Ivermectin: A
possible allosteric effector of the alpha 7 neuronal nicotinic
acetylcholine receptor. Mol Pharmacol. 53:283–294. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sak K: Chemotherapy and dietary
phytochemical agents. Chemother Res Pract.
2012:2825702012.PubMed/NCBI
|
|
45
|
You HB and Park K: Targeted drug delivery
to tumors: Myths, reality and possibility. J Control Release.
153:198–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
